Agilent ACEA xCELLigence RTCA CardioECR Real-Time Cell Analyzer System for Cardiomyocyte Monitoring

The Agilent ACEA xCELLigence RTCA CardioECR System is a compact, advanced laboratory instrument designed for real-time, label-free monitoring of cardiomyocyte function. Featuring combined impedance measurement and field potential (FP) recording, it enables precise detection of changes in contractility, viability, and electrophysiological properties without invasive interventions, preserving native cellular behavior.

Key technical specifications include:

This system is widely used in cardiac safety pharmacology, drug discovery, molecular diagnostics, and biotechnology research fields focused on bioprocessing, gene editing, and synthetic biology applications involving cardiac cells. It supports both acute (seconds to minutes) and long-term (hours to days) assays critical for biopharmaceutical production pipelines and cell-based functional assays.

The provided package includes the xCELLigence RTCA CardioECR Analyzer (Model W600), a 48-station E-Plate CardioECR (Model 1x48), a computer with RTCA CardioECR trial software, and necessary power/communication cables. The instrument undergoes comprehensive servicing with confirmed operational integrity including electronics inspection, software communication verification, plate recognition, and resistance checks.

Researchers and laboratory professionals will benefit from its high sensitivity and reproducibility for cardiomyocyte electrophysiology and contractility assessment. The system contributes to enhanced workflows in molecular cloning, bioprocess monitoring, and cardiotoxicity testing within biomedical engineering and clinical diagnostics domains.

This pre-owned system comes with warranty coverage, remote setup assistance, and training support, making it ideal for laboratories focused on live-cell imaging, fluorescence analysis, and synthetic biology research seeking a robust and reliable cardiomyocyte analysis platform.